FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2049649193> ?p ?o ?g. }

• W2049649193 endingPage "1180" @default.
• W2049649193 startingPage "1173" @default.
• W2049649193 abstract "To compare the dose distribution to targeted and nontargeted tissues in Hodgkin's lymphoma patients using conventional radiotherapy (CRT), intensity-modulated RT (IMRT), and three-dimensional proton RT (3D-PRT).CRT, IMRT, and 3D-PRT treatment plans delivering 30 cobalt Gray equivalent (CGE)/Gy to an involved nodal field were created for 9 Stage II Hodgkin's lymphoma patients (n = 27 plans). The dosimetric endpoints were compared.The planning target volume was adequately treated using all three techniques. The IMRT plan produced the most conformal high-dose distribution; however, the 3D-PRT plan delivered the lowest mean dose to nontarget tissues, including the breast, lung, and total body. The relative reduction in the absolute lung volume receiving doses of 4-16 CGE/Gy for 3D-PRT compared with CRT ranged from 26% to 37% (p < .05), and the relative reduction in the absolute lung volume receiving doses of 4-10 CGE/Gy for 3D-PRT compared with IMRT was 48-65% (p < .05). The relative reduction in absolute total body volume receiving 4-30 CGE/Gy for 3D-PRT compared with CRT was 47% (p < .05). The relative reduction in absolute total body volume receiving a dose of 4 CGE/Gy for 3D-PRT compared with IMRT was 63% (p = .03). The mean dose to the breast was significantly less for 3D-PRT than for either IMRT or CRT (p = .03) The mean dose and absolute volume receiving 4-30 CGE/Gy for the heart, thyroid, and salivary glands were similar for the three modalities.In this favorable subset of Hodgkin's lymphoma patients without disease in or below the hila, 3D-PRT significantly reduced the dose to the breast, lung, and total body. These observed dosimetric advantages might improve the clinical outcomes of Hodgkin's lymphoma patients by reducing the risk of late radiation effects related to low-to-moderate doses in nontargeted tissues." @default.
• W2049649193 created "2016-06-24" @default.
• W2049649193 creator A5005329877 @default.
• W2049649193 creator A5023899503 @default.
• W2049649193 creator A5036363859 @default.
• W2049649193 creator A5053162153 @default.
• W2049649193 creator A5071374686 @default.
• W2049649193 creator A5080673740 @default.
• W2049649193 creator A5089567961 @default.
• W2049649193 date "2009-11-01" @default.
• W2049649193 modified "2023-10-18" @default.
• W2049649193 title "Dosimetric Comparison of Three Different Involved Nodal Irradiation Techniques for Stage II Hodgkin's Lymphoma Patients: Conventional Radiotherapy, Intensity-Modulated Radiotherapy, and Three-Dimensional Proton Radiotherapy" @default.
• W2049649193 cites W1833833181 @default.
• W2049649193 cites W1912609891 @default.
• W2049649193 cites W1964918642 @default.
• W2049649193 cites W1971261928 @default.
• W2049649193 cites W1974822231 @default.
• W2049649193 cites W2003897619 @default.
• W2049649193 cites W2008700492 @default.
• W2049649193 cites W2017960005 @default.
• W2049649193 cites W2018925169 @default.
• W2049649193 cites W2023416744 @default.
• W2049649193 cites W2028921257 @default.
• W2049649193 cites W2029794276 @default.
• W2049649193 cites W2032968239 @default.
• W2049649193 cites W2040199789 @default.
• W2049649193 cites W2068862043 @default.
• W2049649193 cites W2072093919 @default.
• W2049649193 cites W2082240034 @default.
• W2049649193 cites W2084091979 @default.
• W2049649193 cites W2098179714 @default.
• W2049649193 cites W2104221398 @default.
• W2049649193 cites W2106193652 @default.
• W2049649193 cites W2114574605 @default.
• W2049649193 cites W2121605135 @default.
• W2049649193 cites W2125790189 @default.
• W2049649193 cites W2131305184 @default.
• W2049649193 cites W2136761623 @default.
• W2049649193 cites W2147946394 @default.
• W2049649193 cites W2162084836 @default.
• W2049649193 cites W2163792546 @default.
• W2049649193 cites W2203624818 @default.
• W2049649193 cites W2243890309 @default.
• W2049649193 cites W2322312023 @default.
• W2049649193 cites W4254756961 @default.
• W2049649193 doi "https://doi.org/10.1016/j.ijrobp.2008.12.048" @default.
• W2049649193 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19386423" @default.
• W2049649193 hasPublicationYear "2009" @default.
• W2049649193 type Work @default.
• W2049649193 sameAs 2049649193 @default.
• W2049649193 citedByCount "109" @default.
• W2049649193 countsByYear W20496491932012 @default.
• W2049649193 countsByYear W20496491932013 @default.
• W2049649193 countsByYear W20496491932014 @default.
• W2049649193 countsByYear W20496491932015 @default.
• W2049649193 countsByYear W20496491932016 @default.
• W2049649193 countsByYear W20496491932017 @default.
• W2049649193 countsByYear W20496491932018 @default.
• W2049649193 countsByYear W20496491932019 @default.
• W2049649193 countsByYear W20496491932020 @default.
• W2049649193 countsByYear W20496491932021 @default.
• W2049649193 countsByYear W20496491932022 @default.
• W2049649193 countsByYear W20496491932023 @default.
• W2049649193 crossrefType "journal-article" @default.
• W2049649193 hasAuthorship W2049649193A5005329877 @default.
• W2049649193 hasAuthorship W2049649193A5023899503 @default.
• W2049649193 hasAuthorship W2049649193A5036363859 @default.
• W2049649193 hasAuthorship W2049649193A5053162153 @default.
• W2049649193 hasAuthorship W2049649193A5071374686 @default.
• W2049649193 hasAuthorship W2049649193A5080673740 @default.
• W2049649193 hasAuthorship W2049649193A5089567961 @default.
• W2049649193 hasConcept C126838900 @default.
• W2049649193 hasConcept C146357865 @default.
• W2049649193 hasConcept C151730666 @default.
• W2049649193 hasConcept C2989005 @default.
• W2049649193 hasConcept C509974204 @default.
• W2049649193 hasConcept C71924100 @default.
• W2049649193 hasConcept C86803240 @default.
• W2049649193 hasConceptScore W2049649193C126838900 @default.
• W2049649193 hasConceptScore W2049649193C146357865 @default.
• W2049649193 hasConceptScore W2049649193C151730666 @default.
• W2049649193 hasConceptScore W2049649193C2989005 @default.
• W2049649193 hasConceptScore W2049649193C509974204 @default.
• W2049649193 hasConceptScore W2049649193C71924100 @default.
• W2049649193 hasConceptScore W2049649193C86803240 @default.
• W2049649193 hasIssue "4" @default.
• W2049649193 hasLocation W20496491931 @default.
• W2049649193 hasLocation W20496491932 @default.
• W2049649193 hasOpenAccess W2049649193 @default.
• W2049649193 hasPrimaryLocation W20496491931 @default.
• W2049649193 hasRelatedWork W1841185769 @default.
• W2049649193 hasRelatedWork W2022944059 @default.
• W2049649193 hasRelatedWork W2048191766 @default.
• W2049649193 hasRelatedWork W2155887765 @default.
• W2049649193 hasRelatedWork W2356105190 @default.
• W2049649193 hasRelatedWork W2380330452 @default.
• W2049649193 hasRelatedWork W2384708512 @default.
• W2049649193 hasRelatedWork W2428341374 @default.

• next